🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
NXT
$NXTC
🔒 US EquitiesNextCure Inc
AVG HISTORICAL GAP
-0.71%
MAX GAP RECORD
+7.38%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $NXTC
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$NXTC
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Aug 06, 2026 Earnings Release 2026-08-06 (AFTER CLOSE) |
-5.72%
|
| May 07, 2026 Earnings Release 2026-05-07 (AFTER CLOSE) |
+0.00%
|
| Mar 05, 2026 Earnings Release 2026-03-05 (AFTER CLOSE) |
-0.16%
|
| Nov 05, 2025 Earnings Release 2025-11-05 (AFTER CLOSE) |
-1.14%
|
| Aug 07, 2025 Earnings Release 2025-08-07 (AFTER CLOSE) |
-3.63%
|
| Apr 30, 2025 Earnings Release 2025-04-30 (AFTER CLOSE) |
-4.95%
|
| Mar 06, 2025 Earnings Release 2025-03-06 (AFTER CLOSE) |
+4.07%
|
| Nov 07, 2024 Earnings Release 2024-11-07 (AFTER CLOSE) |
+2.20%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
3.2%
Bullish Gaps (3)
Bearish Gaps (6)
Neutral / Flat (3)
📖 Intelligence Summary
NextCure, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering and developing immunomedicines to treat cancer and other immune-related diseases. Its novel FIND-IO discovery technology identifies targets based on immunomodulatory function and on which the company is building a proprietary pipeline of immunomedicines. The company was founded by Michael…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗